Company Updates
Aussie Small Cap Biotechs March Up: Resonance Health, Analytica, Sunshine Heart
The broader Australian market finished the day 3.4 points higher at 4,568 points led largely by the materials and financial stocks. The healthcare sector failed to excite with a loss of 40.2 points, however a handful of medical stocks managed to wind the day up in the positive. ——- To view the full article, please […]
Viralytics: Phase 2 Melanoma Clinical Trial – CAVATAK™
Viralytics Limited (ASX: VLA, OTC: VRACY): is pleased to provide an update on progress with our Phase 2 CAVATAK™ clinical trial for late stage melanoma, currently being conducted under an IND in the US. The highlights include: 13 subjects have now been dosed with CAVATAK™ out of an approximate target of 63 subjects; 3 of 13 […]
FerriScan Contracted for Two New Clinical Trials
Resonance Health has executed two multi-year contracts with a pharmaceutical company to provide FerriScan services, for an undisclosed sum. One contract will involve Resonance Health working with up to 15 MRI facilities that will image patients participating in the clinical trial. Resonance Health will provide FerriScan image analysis services to measure liver iron concentration and […]
Power to car buyers and enthusiasts
CarAdvice is re-inventing the way people buy cars online. Launched in 2006 but only commercialised since 2009, CarAdvice has audience of more than 1 million visits each month, and is ranked as Australia’s number five auto site according to Nielsen Market Intelligence. The CarAdvice site is already the largest independent player in the online automotive […]
Wholesale Investor National Investor Sentiment Index FY13 Q2
Please find attached the latest National Investor Sentiment Index from Wholesale Investor. Below are the key highlights from the survey. A PDF download of the complete results is provided below. • Investors remain optimistic – 77% of investors are positive about the Australian economy over the next 2 years • Investors have been investing – […]
Plenty of upside for Real Estate Investar
Online property research portal Real Estate Investar (REI) became profitable on a monthly basis in April of this year but, with its current subscriber base making up less than 0.2 percent of its target market, the group is confident there is significant upside in its business model. REI is a research portal offering a unique […]
FDA requests a broader Indication for Use for FerriScan
The Food and Drug Administration (FDA) has requested Resonance Health to submit an expanded Indication for Use for FerriScan to include its specific role in the use of iron chelation therapy. Following this change, FerriScan would be considered to be a companion diagnostic device which provides information that is considered essential for the safe and […]
Cobar Consolidated Resources Ltd Issues New Ordinary Shares
Cobar Consolidated Resources Ltd announced that it has issued 4,220,834 ordinary shares at an issue price of AUD 0.60 per share. The shares are issued pursuant to Share Purchase Plan to shareholders to increase Company’s working capital position and allow a number of development opportunities to be brought forward at Wonawinta Silver Project. —- To […]
Successful Fund Raising for Clean Power Company, BioSyngas Pty Ltd.
Syngas Limited’s (Syngas) [ASX: SYS] Board of Directors is pleased to announce that $500,000 has been raised successfully for Syngas’ renewable/clean energy subsidiary company, BioSyngas Pty Ltd (BioSyngas). Funds received secured a forty (40) percent stake in BioSyngas under the terms and conditions set out in the BioSyngas Information Memorandum released on 1st June 2012, […]
Backed By Leading Investment Groups and Family Offices
